Page last updated: 2024-11-04
temozolomide and Androgen-Independent Prostatic Cancer
temozolomide has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Hussain, M | 1 |
| Carducci, MA | 1 |
| Slovin, S | 1 |
| Cetnar, J | 1 |
| Qian, J | 1 |
| McKeegan, EM | 1 |
| Refici-Buhr, M | 1 |
| Chyla, B | 1 |
| Shepherd, SP | 1 |
| Giranda, VL | 1 |
| Alumkal, JJ | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| A Pilot Study Combining ABT-888, an Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Castration Resistant Prostate Cancer Who Have Failed Up to Two Non-hormonal Systemic Therapies[NCT01085422] | Phase 1 | 35 participants (Actual) | Interventional | 2010-04-30 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trials
1 trial available for temozolomide and Androgen-Independent Prostatic Cancer